We are live on ! Find out more
KZR

Kezar Life Sciences
KZR

Delisted

KZR was delisted on the 8th of May, 2026.

Back to rankings

132 hedge funds and large institutions have $480M invested in Kezar Life Sciences in 2022 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 60 increasing their positions, 31 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

409% more call options, than puts

Call options by funds: $9.9M | Put options by funds: $1.95M

94% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 31

25% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 20

9% more capital invested

Capital invested by funds: $442M → $480M (+$38.1M)

4% more funds holding

Funds holding: 127 → 132 (+5)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

0.67% less ownership

Funds ownership: 9.09% → 8.42% (-0.67%)

Holders
132
Holders Change
+5
Holders Change %
+3.94%
% of All Funds
2.27%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
25
Increased
60
Reduced
31
Closed
20
Calls
$9.9M
Puts
$1.95M
Net Calls
+$7.96M
Net Calls Change
-$19M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$27.2M
2
APM
Avidity Partners Management
Texas
+$13.3M
3
SFM
Sphera Funds Management
Israel
+$9.19M
4
N
Nuveen
North Carolina
+$7.78M
5
NHAS
Novo Holdings A/S
Denmark
+$5.81M

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$13.3M
2
Marshall Wace
Marshall Wace
United Kingdom
-$12.1M
3
DM
Deerfield Management
New York
-$11.7M
4
SCM
Suvretta Capital Management
New York
-$11M
5
CAM
Cormorant Asset Management
Massachusetts
-$9.92M
Name Holding Trade Value Shares
Change 		Change in
Stake
PAI
26
Palo Alto Investors
California
$5.65M – – –
NHAS
27
Novo Holdings A/S
Denmark
$5.15M +$5.81M +59,838 New
WP
28
Woodline Partners
California
$5M +$5.64M +58,018 New
GTC
29
Ghost Tree Capital
New York
$4.52M +$729K +7,500 +17%
Two Sigma Advisers
30
Two Sigma Advisers
New York
$4.07M -$1.77M -18,210 -28%
GIM
31
Granahan Investment Management
Massachusetts
$3.85M +$1.66M +17,126 +62%
Schroder Investment Management Group
32
Schroder Investment Management Group
United Kingdom
$3.61M +$1.6M +16,420 +64%
GCM
33
Graham Capital Management
Connecticut
$3.32M +$151K +1,551 +4%
Deutsche Bank
34
Deutsche Bank
Germany
$2.59M +$486 +5 +0%
Connor, Clark & Lunn Investment Management (CC&L)
35
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$2.35M +$295K +3,032 +13%
Rafferty Asset Management
36
Rafferty Asset Management
New York
$2.11M +$2.38M +24,459 New
Bank of America
37
Bank of America
North Carolina
$2M +$2.13M +21,935 +1,758%
Citigroup
38
Citigroup
New York
$1.92M +$2.12M +21,805 +4,122%
Adage Capital Partners
39
Adage Capital Partners
Massachusetts
$1.72M -$2.72M -28,000 -58%
Bank of New York Mellon
40
Bank of New York Mellon
New York
$1.57M +$329K +3,387 +23%
MCM
41
Moore Capital Management
New York
$1.55M -$481K -4,947 -22%
Barclays
42
Barclays
United Kingdom
$1.32M +$1.45M +14,918 +3,702%
Russell Investments Group
43
Russell Investments Group
United Kingdom
$1.31M +$395K +4,068 +36%
SC
44
Slow Capital
California
$1.3M +$1.46M +15,066 New
Morgan Stanley
45
Morgan Stanley
New York
$1.21M -$185K -1,907 -12%
Charles Schwab
46
Charles Schwab
California
$1.19M +$191K +1,965 +17%
SSA
47
Schonfeld Strategic Advisors
New York
$1.08M -$485K -4,989 -28%
BNP Paribas Financial Markets
48
BNP Paribas Financial Markets
France
$986K +$953K +9,807 +595%
Fidelity Investments
49
Fidelity Investments
Massachusetts
$978K +$2.53K +26 +0.2%
Swiss National Bank
50
Swiss National Bank
Switzerland
$925K +$70K +720 +7%
1
2
3 4 5

KZR Hedge Fund Activity: Q3 2022 in Review

132 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Kezar Life Sciences (KZR) for Q3 2022, worth a combined $480M — up 8.6% from $442M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new KZR positions and 20 closed out — a net gain of 5 holders — while 60 added to existing stakes and 31 trimmed.

The largest buyer was State Street, adding an estimated $27.2M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $13.3M sold.

  • 132 institutional investors held Kezar Life Sciences (KZR) as of Q3 2022, up from 127 in Q2 2022.
  • Funds reported $480M of Kezar Life Sciences stock for Q3 2022, up 8.6% quarter-over-quarter.
  • 25 funds opened new Kezar Life Sciences positions in Q3 2022 and 20 closed out, a net change of +5 holders.
  • The largest Kezar Life Sciences buyer in Q3 2022 was State Street, an estimated $27.2M added.
  • The largest Kezar Life Sciences seller in Q3 2022 was Point72 Asset Management, an estimated $13.3M sold.

Based on aggregated 13F filings for Q3 2022.